Cerebral venous sinus thrombosis following tamoxifen prescription

Neurosciences

Volumn 13, Issue 3, 2008, Pages 320-

  Fatehi, Farzad ^a,b   Saadatnia, Mohammad ^a,b,c   Zare, Mohammad ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TAMOXIFEN;

ADULT; ARTICLE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEADACHE; HUMAN; HYSTERECTOMY; LIMB WEAKNESS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PAPILLEDEMA; TONIC CLONIC SEIZURE; UTERUS BLEEDING;

EID: 47749153739     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Bushnell C. The cerebrovascular risks associated with tamoxifen use. Expert Opin Drug Saf 2005; 4: 501-507.
2. Bushnell CD, Goldstein LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 2004; 63: 1230-1233.
3. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006; 295: 2727-2741.
4. Kujovich JL. Hormones and pregnancy: thromboembolic risks for women. Br J Haematol 2004; 126: 443-454.
5. Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology 2000; 54: 1222-1226.